BIOMERIEUX (BIM.PA) Stock Fundamental Analysis
EPA:BIM - Euronext Paris - Matif - FR0013280286 - Common Stock - Currency: EUR
We assign a fundamental rating of 6 out of 10 to BIM. BIM was compared to 55 industry peers in the Health Care Equipment & Supplies industry. While BIM has a great health rating, its profitability is only average at the moment. BIM has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
BIM had positive earnings in the past year.
BIM had a positive operating cash flow in the past year.
Each year in the past 5 years BIM has been profitable.
In the past 5 years BIM always reported a positive cash flow from operatings.
1.2 Ratios
BIM has a better Return On Assets (7.49%) than 78.18% of its industry peers.
BIM has a better Return On Equity (10.28%) than 72.73% of its industry peers.
The Return On Invested Capital of BIM (9.33%) is better than 80.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for BIM is in line with the industry average of 8.22%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.49% | ||
| ROE | 10.28% | ||
| ROIC | 9.33% |
ROA(3y)7.67%
ROA(5y)9.27%
ROE(3y)10.79%
ROE(5y)13.66%
ROIC(3y)10.05%
ROIC(5y)11.9%
1.3 Margins
BIM has a Profit Margin of 10.86%. This is in the better half of the industry: BIM outperforms 69.09% of its industry peers.
BIM's Profit Margin has been stable in the last couple of years.
BIM has a Operating Margin of 14.79%. This is in the better half of the industry: BIM outperforms 70.91% of its industry peers.
BIM's Operating Margin has improved in the last couple of years.
BIM's Gross Margin of 55.66% is in line compared to the rest of the industry. BIM outperforms 47.27% of its industry peers.
BIM's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.79% | ||
| PM (TTM) | 10.86% | ||
| GM | 55.66% |
OM growth 3Y-12.86%
OM growth 5Y2.09%
PM growth 3Y-15.19%
PM growth 5Y1.26%
GM growth 3Y-2.07%
GM growth 5Y0.3%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), BIM is creating some value.
Compared to 1 year ago, BIM has about the same amount of shares outstanding.
BIM has less shares outstanding than it did 5 years ago.
The debt/assets ratio for BIM has been reduced compared to a year ago.
2.2 Solvency
BIM has an Altman-Z score of 7.10. This indicates that BIM is financially healthy and has little risk of bankruptcy at the moment.
BIM's Altman-Z score of 7.10 is amongst the best of the industry. BIM outperforms 90.91% of its industry peers.
The Debt to FCF ratio of BIM is 1.53, which is an excellent value as it means it would take BIM, only 1.53 years of fcf income to pay off all of its debts.
BIM has a Debt to FCF ratio of 1.53. This is amongst the best in the industry. BIM outperforms 85.45% of its industry peers.
A Debt/Equity ratio of 0.08 indicates that BIM is not too dependend on debt financing.
BIM has a better Debt to Equity ratio (0.08) than 85.45% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 1.53 | ||
| Altman-Z | 7.1 |
ROIC/WACC1.21
WACC7.74%
2.3 Liquidity
A Current Ratio of 2.20 indicates that BIM has no problem at all paying its short term obligations.
With a decent Current ratio value of 2.20, BIM is doing good in the industry, outperforming 65.45% of the companies in the same industry.
BIM has a Quick Ratio of 1.29. This is a normal value and indicates that BIM is financially healthy and should not expect problems in meeting its short term obligations.
BIM's Quick ratio of 1.29 is fine compared to the rest of the industry. BIM outperforms 61.82% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.2 | ||
| Quick Ratio | 1.29 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 21.01% over the past year.
BIM shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.91% yearly.
Looking at the last year, BIM shows a quite strong growth in Revenue. The Revenue has grown by 8.31% in the last year.
The Revenue has been growing by 8.27% on average over the past years. This is quite good.
EPS 1Y (TTM)21.01%
EPS 3Y-8.75%
EPS 5Y10.91%
EPS Q2Q%10.71%
Revenue 1Y (TTM)8.31%
Revenue growth 3Y5.64%
Revenue growth 5Y8.27%
Sales Q2Q%9.1%
3.2 Future
The Earnings Per Share is expected to grow by 13.37% on average over the next years. This is quite good.
The Revenue is expected to grow by 6.35% on average over the next years.
EPS Next Y20.14%
EPS Next 2Y16.12%
EPS Next 3Y15.21%
EPS Next 5Y13.37%
Revenue Next Year7.29%
Revenue Next 2Y7.04%
Revenue Next 3Y7.59%
Revenue Next 5Y6.35%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 32.46, the valuation of BIM can be described as expensive.
67.27% of the companies in the same industry are more expensive than BIM, based on the Price/Earnings ratio.
BIM is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 28.04, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 27.02 indicates a quite expensive valuation of BIM.
The rest of the industry has a similar Price/Forward Earnings ratio as BIM.
BIM's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 37.64.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.46 | ||
| Fwd PE | 27.02 |
4.2 Price Multiples
65.45% of the companies in the same industry are more expensive than BIM, based on the Enterprise Value to EBITDA ratio.
63.64% of the companies in the same industry are more expensive than BIM, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 46.13 | ||
| EV/EBITDA | 16.54 |
4.3 Compensation for Growth
BIM's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
BIM has a very decent profitability rating, which may justify a higher PE ratio.
BIM's earnings are expected to grow with 15.21% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.61
PEG (5Y)2.98
EPS Next 2Y16.12%
EPS Next 3Y15.21%
5. Dividend
5.1 Amount
With a yearly dividend of 0.76%, BIM is not a good candidate for dividend investing.
BIM's Dividend Yield is a higher than the industry average which is at 2.07.
Compared to an average S&P500 Dividend Yield of 2.35, BIM's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.76% |
5.2 History
The dividend of BIM is nicely growing with an annual growth rate of 19.40%!
Dividend Growth(5Y)19.4%
Div Incr Years1
Div Non Decr Years7
5.3 Sustainability
23.18% of the earnings are spent on dividend by BIM. This is a low number and sustainable payout ratio.
BIM's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP23.18%
EPS Next 2Y16.12%
EPS Next 3Y15.21%
EPA:BIM (7/25/2025, 7:00:00 PM)
125.3
-0.3 (-0.24%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners20.89%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap14.83B
Analysts75.29
Price Target127.5 (1.76%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.76% |
Yearly Dividend0.85
Dividend Growth(5Y)19.4%
DP23.18%
Div Incr Years1
Div Non Decr Years7
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-1.57%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.46%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.46 | ||
| Fwd PE | 27.02 | ||
| P/S | 3.73 | ||
| P/FCF | 46.13 | ||
| P/OCF | 22.22 | ||
| P/B | 3.53 | ||
| P/tB | 4.97 | ||
| EV/EBITDA | 16.54 |
EPS(TTM)3.86
EY3.08%
EPS(NY)4.64
Fwd EY3.7%
FCF(TTM)2.72
FCFY2.17%
OCF(TTM)5.64
OCFY4.5%
SpS33.63
BVpS35.53
TBVpS25.2
PEG (NY)1.61
PEG (5Y)2.98
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.49% | ||
| ROE | 10.28% | ||
| ROCE | 12.7% | ||
| ROIC | 9.33% | ||
| ROICexc | 9.83% | ||
| ROICexgc | 13.6% | ||
| OM | 14.79% | ||
| PM (TTM) | 10.86% | ||
| GM | 55.66% | ||
| FCFM | 8.08% |
ROA(3y)7.67%
ROA(5y)9.27%
ROE(3y)10.79%
ROE(5y)13.66%
ROIC(3y)10.05%
ROIC(5y)11.9%
ROICexc(3y)11.26%
ROICexc(5y)13.92%
ROICexgc(3y)17.24%
ROICexgc(5y)22.12%
ROCE(3y)13.71%
ROCE(5y)16.2%
ROICexcg growth 3Y-22.62%
ROICexcg growth 5Y-8.16%
ROICexc growth 3Y-19.11%
ROICexc growth 5Y-1.66%
OM growth 3Y-12.86%
OM growth 5Y2.09%
PM growth 3Y-15.19%
PM growth 5Y1.26%
GM growth 3Y-2.07%
GM growth 5Y0.3%
F-Score7
Asset Turnover0.69
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 1.53 | ||
| Debt/EBITDA | 0.39 | ||
| Cap/Depr | 106.34% | ||
| Cap/Sales | 8.69% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 73.01% | ||
| Profit Quality | 74.39% | ||
| Current Ratio | 2.2 | ||
| Quick Ratio | 1.29 | ||
| Altman-Z | 7.1 |
F-Score7
WACC7.74%
ROIC/WACC1.21
Cap/Depr(3y)244.38%
Cap/Depr(5y)271.63%
Cap/Sales(3y)8.63%
Cap/Sales(5y)8.67%
Profit Quality(3y)48.66%
Profit Quality(5y)62.08%
High Growth Momentum
Growth
EPS 1Y (TTM)21.01%
EPS 3Y-8.75%
EPS 5Y10.91%
EPS Q2Q%10.71%
EPS Next Y20.14%
EPS Next 2Y16.12%
EPS Next 3Y15.21%
EPS Next 5Y13.37%
Revenue 1Y (TTM)8.31%
Revenue growth 3Y5.64%
Revenue growth 5Y8.27%
Sales Q2Q%9.1%
Revenue Next Year7.29%
Revenue Next 2Y7.04%
Revenue Next 3Y7.59%
Revenue Next 5Y6.35%
EBIT growth 1Y34.12%
EBIT growth 3Y-7.95%
EBIT growth 5Y10.54%
EBIT Next Year61.98%
EBIT Next 3Y26.54%
EBIT Next 5Y19.07%
FCF growth 1Y200.19%
FCF growth 3Y-15.59%
FCF growth 5Y18.88%
OCF growth 1Y49.82%
OCF growth 3Y-6.82%
OCF growth 5Y10.35%